Strategy Asset Managers’s Idexx Laboratories IDXX Stock Holding History

Strategy Asset Managers’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-624	Closed	-$411K	–	265
2021 Q4	$411K	Buy	624 +277	+80%	+$174K	0.11%	137
2021 Q3	$216K	Sell	347 -1,593	-82%	-$1.07M	0.05%	254
2021 Q2	$1.23M	Buy	1,940 +2	+0.1%	+$1.1K	0.26%	77
2021 Q1	$948K	Buy	1,938 +128	+7%	+$64.1K	0.22%	81
2020 Q4	$905K	Sell	1,810 -143	-7%	-$64K	0.22%	84
2020 Q3	$767K	Buy	+1,953	New	+$722K	0.2%	96
2019 Q1	–	Sell	-6,980	Closed	-$1.3M	–	218
2018 Q4	$1.3M	Sell	6,980 -6,699	-49%	-$1.37M	0.32%	74
2018 Q3	$3.42M	Buy	+13,679	New	+$3.32M	0.69%	39
2018 Q1	–	Sell	-15,635	Closed	-$2.44M	–	123
2017 Q4	$2.44M	Sell	15,635 -169	-1%	-$26.6K	0.48%	73
2017 Q3	$2.46M	Buy	+15,804	New	+$2.5M	0.5%	72

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Strategy Asset Managers's IDXX Position: Q1 2022 in Review

Strategy Asset Managers sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 624 shares — an estimated $411K sold.

Strategy Asset Managers first reported a position in IDXX in Q3 2017 and held it in 10 quarters. The position peaked at $3.42M in Q3 2018. 1,033 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

Strategy Asset Managers reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
Strategy Asset Managers sold 624 Idexx Laboratories shares in Q1 2022, an estimated $411K.
Strategy Asset Managers first reported a position in Idexx Laboratories in Q3 2017 and held it in 10 quarters.
Strategy Asset Managers's Idexx Laboratories position peaked at $3.42M in Q3 2018.
1,033 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Strategy Asset Managers's 13F filing for Q1 2022, filed 11 Apr 2022.